Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
USD 25.04
(-1.14%)
USD 25.04
(-1.14%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 241.75 Million USD | 85.77% |
| 2022 | 130.13 Million USD | 48.9% |
| 2021 | 87.39 Million USD | 185.19% |
| 2020 | 30.64 Million USD | -3.22% |
| 2019 | 31.66 Million USD | 28.21% |
| 2018 | 24.7 Million USD | 15.95% |
| 2017 | 21.3 Million USD | 2.34% |
| 2016 | 20.81 Million USD | 34.15% |
| 2015 | 15.51 Million USD | 641.66% |
| 2014 | 2.09 Million USD | 221.54% |
| 2013 | 650.62 Thousand USD | -8.31% |
| 2012 | 709.55 Thousand USD | -61.87% |
| 2011 | 1.86 Million USD | 33.83% |
| 2010 | 1.39 Million USD | 27.0% |
| 2009 | 1.09 Million USD | 43.31% |
| 2008 | 763.99 Thousand USD | 1.83% |
| 2007 | 750.24 Thousand USD | 15056.38% |
| 2006 | 4950.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 235.33 Million USD | -2.66% |
| 2024 Q2 | 248.45 Million USD | 5.58% |
| 2023 Q2 | 201.93 Million USD | 3.04% |
| 2023 Q4 | 241.75 Million USD | 14.76% |
| 2023 Q3 | 210.66 Million USD | 4.32% |
| 2023 FY | 241.75 Million USD | 85.77% |
| 2023 Q1 | 195.97 Million USD | 50.59% |
| 2022 Q4 | 130.13 Million USD | 32.62% |
| 2022 Q3 | 98.13 Million USD | 5.89% |
| 2022 Q2 | 92.66 Million USD | 5.47% |
| 2022 FY | 130.13 Million USD | 48.9% |
| 2022 Q1 | 87.85 Million USD | 0.53% |
| 2021 FY | 87.39 Million USD | 185.19% |
| 2021 Q4 | 87.39 Million USD | 0.96% |
| 2021 Q1 | 28.38 Million USD | -7.39% |
| 2021 Q3 | 86.56 Million USD | 2.91% |
| 2021 Q2 | 84.11 Million USD | 196.38% |
| 2020 Q4 | 30.64 Million USD | -11.28% |
| 2020 Q2 | 34.05 Million USD | 6.88% |
| 2020 Q3 | 34.54 Million USD | 1.42% |
| 2020 Q1 | 31.86 Million USD | 0.63% |
| 2020 FY | 30.64 Million USD | -3.22% |
| 2019 Q4 | 31.66 Million USD | 2.25% |
| 2019 Q2 | 30.15 Million USD | 2.32% |
| 2019 Q1 | 29.47 Million USD | 19.34% |
| 2019 FY | 31.66 Million USD | 28.21% |
| 2019 Q3 | 30.97 Million USD | 2.69% |
| 2018 Q1 | 21.11 Million USD | -0.87% |
| 2018 Q4 | 24.7 Million USD | 3.62% |
| 2018 Q3 | 23.83 Million USD | 5.49% |
| 2018 Q2 | 22.59 Million USD | 7.01% |
| 2018 FY | 24.7 Million USD | 15.95% |
| 2017 FY | 21.3 Million USD | 2.34% |
| 2017 Q4 | 21.3 Million USD | -5.18% |
| 2017 Q3 | 22.46 Million USD | 12.61% |
| 2017 Q2 | 19.95 Million USD | -2.98% |
| 2017 Q1 | 20.56 Million USD | -1.22% |
| 2016 Q4 | 20.81 Million USD | 11.4% |
| 2016 FY | 20.81 Million USD | 34.15% |
| 2016 Q2 | 16.44 Million USD | -0.49% |
| 2016 Q3 | 18.68 Million USD | 13.65% |
| 2016 Q1 | 16.52 Million USD | 6.48% |
| 2015 Q3 | 12.77 Million USD | 10.01% |
| 2015 FY | 15.51 Million USD | 641.66% |
| 2015 Q1 | 3.16 Million USD | 51.48% |
| 2015 Q2 | 11.61 Million USD | 266.49% |
| 2015 Q4 | 15.51 Million USD | 21.44% |
| 2014 Q1 | 655.46 Thousand USD | 0.74% |
| 2014 Q4 | 2.09 Million USD | -1.49% |
| 2014 Q3 | 2.12 Million USD | 15.73% |
| 2014 Q2 | 1.83 Million USD | 179.96% |
| 2014 FY | 2.09 Million USD | 221.54% |
| 2013 Q1 | 848.54 Thousand USD | 19.59% |
| 2013 FY | 650.62 Thousand USD | -8.31% |
| 2013 Q4 | 650.62 Thousand USD | -38.54% |
| 2013 Q3 | 1.05 Million USD | -4.45% |
| 2013 Q2 | 1.1 Million USD | 30.56% |
| 2012 Q2 | 491.19 Thousand USD | -47.21% |
| 2012 FY | 709.55 Thousand USD | -61.87% |
| 2012 Q4 | 709.55 Thousand USD | 5.93% |
| 2012 Q1 | 930.49 Thousand USD | -50.0% |
| 2012 Q3 | 669.84 Thousand USD | 36.37% |
| 2011 Q1 | 1.53 Million USD | 10.37% |
| 2011 FY | 1.86 Million USD | 33.83% |
| 2011 Q3 | 1.64 Million USD | 3.05% |
| 2011 Q2 | 1.59 Million USD | 4.19% |
| 2011 Q4 | 1.86 Million USD | 12.94% |
| 2010 FY | 1.39 Million USD | 27.0% |
| 2010 Q1 | 1.05 Million USD | -3.74% |
| 2010 Q2 | 1.46 Million USD | 39.41% |
| 2010 Q3 | 1.39 Million USD | -4.73% |
| 2010 Q4 | 1.39 Million USD | -0.66% |
| 2009 FY | 1.09 Million USD | 43.31% |
| 2009 Q4 | 1.09 Million USD | 21.48% |
| 2009 Q3 | 901.24 Thousand USD | -12.37% |
| 2009 Q2 | 1.02 Million USD | -17.4% |
| 2009 Q1 | 1.24 Million USD | 62.98% |
| 2008 Q3 | 607.46 Thousand USD | -34.03% |
| 2008 Q1 | 471.16 Thousand USD | -37.2% |
| 2008 Q4 | 763.99 Thousand USD | 25.77% |
| 2008 FY | 763.99 Thousand USD | 1.83% |
| 2008 Q2 | 920.77 Thousand USD | 95.43% |
| 2007 FY | 750.24 Thousand USD | 15056.38% |
| 2007 Q2 | 3880.00 USD | -21.62% |
| 2007 Q4 | 750.24 Thousand USD | 208.73% |
| 2007 Q1 | 4950.00 USD | 60.98% |
| 2007 Q3 | 243 Thousand USD | 6163.09% |
| 2006 Q3 | 1200.00 USD | 0.0% |
| 2006 FY | 4950.00 USD | 0.0% |
| 2006 Q4 | 3075.00 USD | 156.25% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 5.38 Million USD | -4387.537% |
| BIMI International Medical Inc. | 30.49 Million USD | -692.704% |
| China Jo-Jo Drugstores, Inc. | 80.76 Million USD | -199.333% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 241.75 Million USD | 0.0% |
| Leafly Holdings, Inc. | 34.29 Million USD | -604.963% |
| Leafly Holdings, Inc. | 34.29 Million USD | -604.963% |
| LifeMD, Inc. | 52.91 Million USD | -356.874% |
| LifeMD, Inc. | 52.91 Million USD | -356.874% |
| TRxADE HEALTH, Inc. | 11.99 Million USD | -1916.194% |
| PetMed Express, Inc. | 78.36 Million USD | -208.508% |
| Walgreens Boots Alliance, Inc. | 68.85 Billion USD | 99.649% |